Machine Learning as a strategic lever in healthcare. Recent advances in Machine Learning (ML) now make it possible for pharmaceutical companies to more accurately identify patient populations, including misdiagnosed patients with rare diseases and other diseases…
“Navigating Routes to Commercial Success in Cell and Gene Therapy,” authored by Franjo Hanzl, VP, Business Development, Commercial, EVERSANA, Dr. Lisa Johnson-Pratt, Strategic, Commercial Advisor, Ananias Ventures and Siddharth Agrawal, Senior Principal, Commercial Strategy, EVERSANA, discusses…
As evolving technologies and societal changes continue to push the use of digital channels and media, the reality is that healthcare professionals, patients and other key stakeholders are increasingly ‘digital natives’, who expect new ways of interacting.…
Navigating the complexities of insurance coverage can be a time consuming and challenging task. Field Reimbursement Managers (FRMs) were introduced as a way to help healthcare providers address issues or challenges related to securing timely access…
Pharmaceutical companies are being challenged to develop more effective delivery mechanisms of their therapies in order to reduce the amount of product waste. Recent changes in legislation, including the Waste Reduction Act of 2022 and adoption…
As we continue to learn more about COVID-19 and how the virus impacts the entire body, more information is coming to light regarding its impact specific to the heart and cardiovascular system. The cardiovascular complications of…
Pharmaceutical companies are facing mounting pressures to better integrate and streamline their annual brand planning approaches to meet stakeholder needs and brand and portfolio goals. Despite being one of the most important commercial exercises in any…
As advances in technology continue to modify the biopharma industry at an increasingly rapid pace, embracing digital innovation is crucial to generating success in today’s modern landscape. In this webinar hosted by Pharmaceutical Executive, industry experts…
Introduction As discussed in our previous paper, Successful Launches in Europe: Complex, But Not Complicated?,, Europe is one of the world’s largest and most important regions of focus for pharmaceutical and biotechnology manufacturers looking to treat…
Europe represents a major pharmaceutical market – it accounts for 22% of the global market, second only to the U.S. in terms of market size and has a large population of over 500 million. Understandably, pharmaceutical…